ASCO Reflections and Highlights Conference 2024 (RP2407A)

December 7, 2024

This program has been postponed until Saturday, December 7th! More details coming soon!

This program will provide the participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting. Oncology/Hematology faculty members from UT Southwestern School of Medicine will provide participants with analysis of the more clinically applicable presentations at this year's ASCO meeting via disease-specific didactic talks and panel discussions. 

Download the program agenda HERE.

Target Audience

This activity is appropriate for Oncologists (from the community and from UT Southwestern), Nurse practitioners, Physician assistants, Oncology Nurses, oncology fellows, residents, and students interested in the treatment of cancer.

Learning Objectives

  1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, hematological malignancies
  2. Discuss the integration of multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer.
Course summary
Available credit: 
  • 5.00 AMA
  • 5.00 Attendance
Course opens: 
03/01/2024
Course expires: 
12/07/2025
Event starts: 
12/07/2024 - 8:00am CST
Event ends: 
12/07/2024 - 3:00pm CST
Cost:
$75.00
Rating: 
0

 

Download the program agenda HERE.

UT Southwestern Medical Center
Dallas, TX 75235
United States

This conference is scheduled to take place in-person. Live-stream and/or Hybrid options are not available. 

Course Director(s)

Sawsan Rashdan

has a financial relationship (Grant Or Contract) with bms;.
Moderator(s)

Sawsan Rashdan

has a financial relationship (Grant Or Contract) with bms;.
Speaker(s)

Larry Anderson, MD, PhD

has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with GSK;.
has a financial relationship (Professional Services) with Cellectar;.
has a financial relationship (Professional Services) with amgen;.
has a financial relationship (Professional Services) with Prothena;.
has a financial relationship (Professional Services) with Abbvie;.
has a financial relationship (Professional Services) with Celgene;.
has a financial relationship (Professional Services) with BMS;.

Isaac Chan, MD, PhD

has no relevant financial relationships to disclose at this time.

David Gerber, MD

has a financial relationship (Grant Or Contract) with Sagimet;.
has a financial relationship (Independent contractor) with Sanofi;.
has a financial relationship (Independent contractor) with Daichii Sankyo;.
has a financial relationship (Grant Or Contract) with Novocure;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Elevation Oncology;.
has a financial relationship (Independent contractor) with Astra Zeneca;.
has a financial relationship (Grant Or Contract) with BerGenBio;.
has a financial relationship (Independent contractor) with Catalyst Therapeutics;.
has a financial relationship (Stock) with Walgreens;.
has a financial relationship (Independent contractor) with Jazz Pharmaceuticals;.
has a financial relationship (Grant Or Contract) with Karyopharm;.
has a financial relationship (Stock) with Gilead;.
has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Intellectual Property Other) with OncoSeer Diagnostics;.

Jade Homsi

has a financial relationship (Professional Services) with Boehringer Ingelheim Pharmaceuticals, Inc.;.

Randall Hughes, M.D, Professor of Internal Medicine

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Syed Kazmi

has a financial relationship (Stock) with Johnson & Johnson;.

Heather McArthur, Heather McArthur, MD, MPH

has a financial relationship (Independent contractor) with Daiichi-Sankyo;.
has a financial relationship (Independent contractor) with Crown Bioscience;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Seattle Genetics;.
has a financial relationship (Independent contractor) with Gilead;.
has a financial relationship (Independent contractor) with Lilly;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Puma Biotechnology;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Immunomedics;.

Tian Zhang, MD, MHS

has a financial relationship (Independent contractor) with Pfizer, MJH Associates, Vaniam, Aptitude Health, PeerView, Clinical Care Options;.
has a financial relationship (Grant Or Contract) with Acerta, Novartis, Merrimack, Abbvie/StemCentrx, Merck, Regeneron, Mirati Therapeutics, Janssen, AstraZeneca, Pfizer, OmniSeq, Personal Genome Diagnostics, Astellas, Eli Lilly, Tempus;.
has a financial relationship (Independent contractor) with Merck, Exelixis, Sanofi-Aventis, Janssen, AstraZeneca, Pfizer, Amgen, BMS, Pharmacyclics, SeaGen, Calithera, Dendreon, QED Therapeutics, Eisai, Aveo Pharmaceuticals, Bayer, Eli Lilly;.

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 5.00 AMA
  • 5.00 Attendance

Price

Cost:
$75.00
Please login or create an account to take this course.

Registration

To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

A $25 handling fee will be deducted from cancellation refunds. Refund requests must be received by email at cmeregistrations@utsouthwestern.edu by June 28, 2024.  No refunds will be made thereafter.